Nivolumab-induced asthma in a patient with non-small-cell lung cancer

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2017-11, Vol.28 (11), p.2891-2891
Hauptverfasser:	Maeno, K., Fukuda, S., Oguri, T., Niimi, A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - adverse effects Antineoplastic Agents, Immunological - administration & dosage Antineoplastic Agents, Immunological - adverse effects Asthma - chemically induced Asthma - immunology Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - immunology Humans Lung Neoplasms - drug therapy Lung Neoplasms - immunology Male Middle Aged Nivolumab Programmed Cell Death 1 Receptor - antagonists & inhibitors Programmed Cell Death 1 Receptor - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!